安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Ibrutinib - Wikipedia
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase (BTK)
- Ibrutinib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, which is used to treat various blood cancers and also a serious complication of allogeneic stem cell transplants called chronic graft versus host disease (cGVHD)
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information
- Ibrutinib (oral route) - Side effects dosage - Mayo Clinic
Ibrutinib can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection It can also lower the number of platelets, which are necessary for proper blood clotting
- Imbruvica (ibrutinib) - Uses, Side Effects, and More - WebMD
Find patient medical information for Imbruvica (ibrutinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Ibrutinib: MedlinePlus Drug Information
Ibrutinib is used to treat adults with chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) and small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes)
- Ibrutinib - NCI - National Cancer Institute
This page contains brief information about ibrutinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
- Ibrutinib - PMC
Ibrutinib is an oral small-molecule drug for B-cell malignancies It works by binding to Bruton’s tyrosine kinase and blocking signalling through the B-cell receptor and cytokine receptor pathways
|
|
|